FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/05/066869 [Registered on: 06/05/2024] Trial Registered Prospectively
Last Modified On: 03/05/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Unani 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Treatment of Painful menstruation with Ajwain khurasani  
Scientific Title of Study   Management of primary dysmenorrhea (usre tams) with Ajwain khurasani in comparison with Mefenamic acid  
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr. M.N.Nasrina Begum 
Designation  PG Scholar, Department of QON,Govt.Nizamia Tibbi College  
Affiliation  Govt.Nizamia Tibbi College and Hospital  
Address  Room no :224,1st floor, PG Department of Obstetrics and Gynaecology,Govt. Nizamia Tibbi College and Hospital. Charminar. Hyderabad

Hyderabad
TELANGANA
500002
India 
Phone  918142050158  
Fax    
Email  muhminasrina@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DrShahzadi sultana 
Designation  Professor, Principal of Govt.Nizamia Tibbi College  
Affiliation  Govt.Nizamia Tibbi College and Hospital  
Address  Room no :224,1st floor, PG Department of Obstetrics and Gynaecology,Govt. Nizamia Tibbi College and Hospital. Charminar. Hyderabad

Hyderabad
TELANGANA
500002
India 
Phone  9908624090  
Fax    
Email  drssntc@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr. M.N.Nasrina Begum 
Designation  PG Scholar,Department of QON, Govt.Nizamia Tibbi College  
Affiliation  Govt.Nizamia Tibbi College and Hospital  
Address  Room no :224,1st floor, PG Department,Govt. Nizamia Tibbi College and Hospital. Charminar. Hyderabad

Hyderabad
TELANGANA
500002
India 
Phone  918142050158  
Fax    
Email  muhminasrina@gmail.com  
 
Source of Monetary or Material Support  
Government Nizamia Tibbi College and General Hospital,Charminar. Hyderabad. India. 500002 
 
Primary Sponsor  
Name  Government Nizamia Tibbi College and Hospital  
Address  Government Nizamia Tibbi College and Hospital, Charminar Hyderabad  
Type of Sponsor  Other [] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DrMNNasrina Begum  Govt.Nizamia Tibbi College and Hospital  PG Department of Obstetrics and Gynecology. Government Nizamia Tibbi College and Hospital Charminar.Hyderabad
Hyderabad
TELANGANA 
8142050158

muhminasrina@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee Govt. Nizamia Tibbi College, Charminar, Hyderabad. Telegana State  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: N944||Primary dysmenorrhea,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Ajwain khurasani (Hyoscyamus niger)  test group will be given joshanda(decoction) of ajwain khurasani 15ml bd with honey 2days before the onset of menstruation till 3rd day of the cycle  
Comparator Agent  Mefenamic acid  Mefenamic acid 250mg bd (1st to 3rd day of cycle) 
 
Inclusion Criteria  
Age From  13.00 Year(s)
Age To  30.00 Year(s)
Gender  Female 
Details  . Patient with regular periods
. Painful menstruation
Age group 13-30 years 
 
ExclusionCriteria 
Details  pregnant women
use of intrauterine device/oral contraceptive pills
organic pelvic pathology
women with systemic illness
women with allergic/ hypersensitive to NSAIDs
 
 
Method of Generating Random Sequence   Other 
Method of Concealment   Other 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
visual analogue scale  3 consecutive menstrual cycle 
 
Secondary Outcome  
Outcome  TimePoints 
efficacy of test & control drug on associated symptoms
fatigue, headache, nausea & vomiting 
for 3 consecutive menstrual cycle 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   15/05/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Dysmenorrhoea literally means painful menstruation or cramping pain accompanying menstruation.Its classified into 2, primary and secondary. Primary dysmenorrhoea is widely prevalent more than 50% of teenagers and 30-50% of menstruating women suffer from various degree of discomfort.
primary dysmenorrhoea is usually confined to adolescent girls. Pain begins few hour before or just with the onset of menstrution. Severity of pain usually lasts for few hours may extend 24hrs .the primary dysmenorrhoea is ine where there is no identifiable pelvic pathology.
it is almost confined to ovulatory cycles. clinical features are the spasmodic pain confined to lower abdomen may radiate to back& medial aspect of thigh,nausea, vomiting, fatigue,diarrhoea, cold sweats,sleeplessness  etc.
 
Close